1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Antibacterial Drugs: World Industry and Market Prospects 2016-2026

  • March 2016
  • 300 pages
  • Visiongain
Report ID: 739371

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
Antibacterial Drugs: World Industry and Market Prospects 2016-2026 – our new study reveals trends, R&D progress, and predicted revenues
Where is the Antibacterial Drugs market heading? Visiongain’s report shows you the potential revenues streams to 2026, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 300 page report provides 124 tables and 97 figures. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibacterial Drugs market.

Forecasts from 2016-2026 and other analyses reveal the commercial prospects
- In addition to revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares.
- You find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including SWOT and STEP analysis), product profiles and commercial developments.
- Read full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including:
- Dr. Holger Zimmermann, Chief Executive Officer (CEO) of AiCuris Anti-infective Cures GmbH
- Discusses the dynamic of the antibacterial drugs market and the company’s drug candidate, AIC499 for the treatment of Gram-negative infections.
- Dr Bruce R. Donald (Duke University) Dr Amy C. Anderson (University of Connecticut), Mr. Pablo Gainza-Cirauqui (Duke University)
- Discusses OSPREY, the protein-design algorithm to predict mutation.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you find revenue forecasts to 2026 for the following submarkets:
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Other antibiotics.

Our investigation discusses what stimulates and restrains business. Understand the dynamics of the industry and assess its potential future sales, discovering the critical factors likely to achieve success.

Predictions of leading products’ sales – what’s possible for those antibacterial drugs?
How will individual antibacterial drugs perform from 2016 to 2026 at world level? Our study forecasts revenues of these brands:
- Cephalosporins
- Rocephin
- Sulperazon
- Ceftin/Zinnat
- Meiact
- Flomox
- Teflaro
- Zeftera
- Ceftolozane-tazobactam
- Ceftazidime-Avibactam
- Penicillins
- Generic amoxicillin
- Augmentin
- Zosyn/Tazocin
- Unasyn
- Generic amoxicllin-clavulanic acid
- Amoxil

- Fluoroquinolones
- Avelox
- Cravit
- Vigamox
- Ciprodex
- Cipro/Cirpobay
- Geninax
- Defafloxacin

- Macrolides
- Biaxin/Clarith
- Zithromax
- Dalacin
- Dificid
- Solithromycin

- Carbapenems
- Invanz
- Merrem/Meropen
- Primaxin
- Doribax

- Other antibiotics
- Zyvox
- Cubicin
- Tygacil
- TOBI/TIP
- Solodyn
- Vibativ
- Sirturo
- Tedizolid
- Oritavancin
- Dalbavancin
- Nemonoxacin
- Surotomycin

Our analysis also divides the main global forecast into geographical markets.

What are the prospects in the leading regions and countries?
You will discover individual revenue forecasts for 12 leading national markets from 2016-2026:
- United States (US)
- Japan
- Germany, France, the UK, Italy and Spain (EU5 group)
- Brazil, Russia, India and China (BRIC countries).
- South Korea

This chapter also provides incidence of infection and antibacterial drug consumption by country.

Leading companies and the potential for market growth
Our analyses forecasts the world market for antibacterial drug market will reach $44.13bn in 2020.

You can also see which companies hold the most potential:
- Pfizer
- Merck & Co.
- GlaxoSmithKline
- Novartis
- Bayer
- Taisho Pharmaceuticals
- AstraZeneca
- Abbott Labs
- Daiichi Sankyo

Research and development - assess innovation, trends and possibilities
Our report discusses R&D, appraising technological, clinical and commercial possibilities.
There are 19 antibacterial drugs in phase III trials. Our report discusses:
- Small Molecule Antibacterial Drugs
- Inhaled Antibacterial Drug Formulations
- Biological Antibacterial Therapeutics
- Other Classes

How the Antibacterial Drug Market report helps you
- Revenues for antibacterial drug market to 2026 – assess the overall world drugs market’s potential and receive forecasted revenues.
- Products’ sales to 2026 – discover the predicted revenues of Zyvox, Cubicin,and Augmentin, amongst other leading brands.
- National market forecasting to 2026 for 12 countries – explore the best regions for treatment demand, sales and growth
- R&D activities – see the progress, trends and prospects in that ophthalmic research and development, finding technological, clinical and commercial possibilities
- Leading companies – examine the participants, including Pfizer, Merck & Co., and GlaxoSmithKline.
- Analysis of what stimulates and restrains that industry and market – assess challenges and strengths there, helping you compete and gain advantage.
- Two interviews with stakeholders in the antibacterial drug market.

Our brand new survey, by our in-house UK-based analysts, provides knowledge to benefit your research, analyses, plans, decisions and proposals. It reveals information you will find nowhere else.

Our investigation provides you with definitive data, trends, opportunities and sales predictions to 2026 for the antibacterial drug market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Infectious Disease Drugs: The Chinese Market

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Assess market dynamics of Chinese market for both communicable and - non-communicable infectious disease drugs, their opportunities and restraints. - Evaluate Chinese drug market ...

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • $ 4995
  • Industry report
  • March 2017
  • by GBI Research

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market Summary Respiratory complications are a ...

Global Feed Antibiotics Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global feed antibiotics market is forecasted to grow at a CAGR of around 1.5%. Antibiotics have been traditionally used in the animal feeds as anti-microbial as well as growth promoters. In addition ...

Penicillin Markets In China

April 2017 $ 4000

Resorcinol Markets In China

April 2017 $ 4000

Cephalosporin Markets In China

April 2017 $ 4000

Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in the US

  • June 2017
    5 pages
  • Anti-Infective  

  • United States  

View report >

Anti-Infective Market in India

  • June 2017
    12 pages
  • Anti-Infective  

    Fish  

  • India  

View report >

Anti-Infective Market in the UK and the US

  • June 2017
    2 pages
  • Anti-Infective  

  • United Kingdom  

    United States  

View report >

Related Market Segments :

Anti-Infective

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.